Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

This site contains information on skin, mouth and hair changes (known as adverse reactions) that can sometimes occur with a particular type of cancer drug, known as multikinase inhibitors. This section is for patients receiving the following cancer treatments only: Cabometyx®/ Cometriq® (cabozantinib), Caprelsa® (vandetanib), Glivec®/ Gleevec® / Imatinib® (imatinib), Lenvima®/ Kisplyx® (lenvatinib), Nexavar® (sorafenib), Rydapt® (midostaurin), Sprycel® (dasatinib), Stivarga® (regorafenib), Sutent® (sunitinib) and Votrient® (pazopanib). Here, we aim to bring you important information on how you can work with your doctor/nurse to manage skin, mouth and hair adverse reactions to your cancer treatment.

Important to Know
A list of general facts and recommendations on adverse reactions associated with multikinase inhibitors

Skin, Nail, Hair and Mouth Changes
A description of the different adverse reactions that can appear with multikinase inhibitors

DOs and DON’Ts
Practical tips on managing these adverse reactions

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.